XENE Research and Charts

XENE - Xenon Pharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2025-08-11 (Delayed quote data 2025-07-11)

Last 32.21	Change ⇓ -0.77 (-2.33%)	Volume 588,824
	Open 32.79	High 33.15	Low 32.10

8EMA (Daily) 32.37	40EMA (Daily) 32.28	50EMA (Daily) 32.48	STO (Daily) 41.387	MACD Hist (Daily) 0.125
8EMA (Weekly) 32.449	40EMA (Weekly) 35.75	50EMA (Weekly) 36.36	STO (Weekly) 47.237	MACD Hist (Weekly) 0.301


Company Profile
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including the rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901 and XEN496 for Epilepsy, XEN007 for Orphan neurological, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out through Canada.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.